source
- Eli Lilly to acquire Merida Biosciences for up to $2.875 billion, bolstering its immunology pipelineEli Lilly announced a deal to purchase Merida Biosciences, a biotech focused on immunology, for a total consideration that could reach $2.875 billion. The acquisition adds Merida's assets in fast-…
- US biotech edge erodes as China overtakes in trials and research, raising security concernsThe United States is losing its lead in biotech as China now conducts more clinical trials and publishes more natural‑science papers. China passed the U.S. six years ago in trial numbers and soon…